全科医学临床与教育
全科醫學臨床與教育
전과의학림상여교육
CLINICAL EDUCATION OF GENERAL PRACTICE
2015年
1期
6-10
,共5页
黄文娟%戴宇%刁然%汪慧英
黃文娟%戴宇%刁然%汪慧英
황문연%대우%조연%왕혜영
高敏C反应蛋白%哮喘%系统性炎症%CD69
高敏C反應蛋白%哮喘%繫統性炎癥%CD69
고민C반응단백%효천%계통성염증%CD69
high sensitivity C reactive protein%asthma%systemic inflammation%CD69
目的测定哮喘小鼠中高敏C反应蛋白(hsCRP)的水平及其与气道炎症的相关性,观察气道炎症的抑制对其表达的影响。方法应用鸡卵白蛋白(OVA)致敏激发制备哮喘小鼠,测定哮喘小鼠血清、支气管肺泡灌洗液(BALF)中hsCRP水平,分析其与气道高反应性(AHR)、气道嗜酸细胞(Eos)和气道黏液分泌的相关性。在哮喘小鼠OVA激发前后分别腹腔注射DXM和anti-CD69mAb,观察它们对哮喘小鼠气道炎症及hsCRP的影响。结果哮喘小鼠血清hsCRP显著高于正常小鼠(P<0.05),且与AHR、BALF中Eos、气管周围Eos浸润及黏液表达正相关(r分别=0.90、0.99、0.96、0.90,P均<0.05);但BALF中hsCRP未有显著增高。 DXM和anti-CD69mAb均可有效地抑制血清hsCRP的增高和哮喘小鼠的气道炎症(P均<0.05)。结论哮喘小鼠存在以CRP为指标的系统性炎症,且其水平与气道局部炎症正相关,而气道炎症的抑制可有效地抑制系统性炎症。
目的測定哮喘小鼠中高敏C反應蛋白(hsCRP)的水平及其與氣道炎癥的相關性,觀察氣道炎癥的抑製對其錶達的影響。方法應用鷄卵白蛋白(OVA)緻敏激髮製備哮喘小鼠,測定哮喘小鼠血清、支氣管肺泡灌洗液(BALF)中hsCRP水平,分析其與氣道高反應性(AHR)、氣道嗜痠細胞(Eos)和氣道黏液分泌的相關性。在哮喘小鼠OVA激髮前後分彆腹腔註射DXM和anti-CD69mAb,觀察它們對哮喘小鼠氣道炎癥及hsCRP的影響。結果哮喘小鼠血清hsCRP顯著高于正常小鼠(P<0.05),且與AHR、BALF中Eos、氣管週圍Eos浸潤及黏液錶達正相關(r分彆=0.90、0.99、0.96、0.90,P均<0.05);但BALF中hsCRP未有顯著增高。 DXM和anti-CD69mAb均可有效地抑製血清hsCRP的增高和哮喘小鼠的氣道炎癥(P均<0.05)。結論哮喘小鼠存在以CRP為指標的繫統性炎癥,且其水平與氣道跼部炎癥正相關,而氣道炎癥的抑製可有效地抑製繫統性炎癥。
목적측정효천소서중고민C반응단백(hsCRP)적수평급기여기도염증적상관성,관찰기도염증적억제대기표체적영향。방법응용계란백단백(OVA)치민격발제비효천소서,측정효천소서혈청、지기관폐포관세액(BALF)중hsCRP수평,분석기여기도고반응성(AHR)、기도기산세포(Eos)화기도점액분비적상관성。재효천소서OVA격발전후분별복강주사DXM화anti-CD69mAb,관찰타문대효천소서기도염증급hsCRP적영향。결과효천소서혈청hsCRP현저고우정상소서(P<0.05),차여AHR、BALF중Eos、기관주위Eos침윤급점액표체정상관(r분별=0.90、0.99、0.96、0.90,P균<0.05);단BALF중hsCRP미유현저증고。 DXM화anti-CD69mAb균가유효지억제혈청hsCRP적증고화효천소서적기도염증(P균<0.05)。결론효천소서존재이CRP위지표적계통성염증,차기수평여기도국부염증정상관,이기도염증적억제가유효지억제계통성염증。
Objective To assay the expression of high sensitivity C reactive protein (hsCRP) in asthmatic mice and its correlation to the airway inflammation, and observe the impact of the inhibition of airway inflammation on it. Methods Asthmatic mice were made by the sensitization and aerosol provocation of ovabulmin (OVA). hsCRP level in serum and bronchoalveolar lavage fluid (BALF) and their correlation to airway hyperrespoinsiveness (AHR), eosinophils and mucus overproduction were assayed. DXM and anti-CD69 mAb were administrated before and after OVA provocation, respective-ly, and their effects on airway inflammation and hsCRP expression were investigated. Results Serum hsCRP level in asth-matic mice was significantly higher than that in the normal mice (P<0.05), and positively correlated with AHR, eosinophils in BALF, peribronchial area, and mucus overproduction (r=0.90,0.99,0.96, 0.90,P<0.05). While hsCRP in BALF of asthmatic mice was at the similar level as normal mice. Treatment of DXM or anti-CD69mAb both inhibited the airway in-flammation, AHR and elevation of hsCRP level in serum effectively. Conclusion Systemic inflammation with the index of hsCRP existed in asthmatic mice, and correlated positively to the airway inflammation. The inhibition of airway inflamma-tion by anti-CD69 mAb could inhibit the systemic inflammation effectively.